Pharmaceutical & Bioscience Society International
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 232,385 | 228,789 | 3,596 | 8.7 | 0% |
| 2012 | 283,631 | 275,468 | 8,163 | 7.6 | 0% |
| 2013 | 411,747 | 440,920 | −29,173 | 4.0 | 0% |
| 2014 | 279,130 | 254,203 | 24,927 | 8.8 | 0% |
| 2015 | 266,897 | 240,835 | 26,062 | 10.5 | 0% |
| 2016 | 292,232 | 253,504 | 38,728 | 11.8 | 0% |
| 2017 | 303,349 | 221,348 | 82,001 | 18.0 | 0% |
| 2018 | 293,228 | 212,367 | 80,861 | 23.3 | 0% |
| 2019 | 310,103 | 271,497 | 38,606 | 21.0 | 0% |
| 2020 | 228,999 | 50,244 | 178,755 | 156.0 | 0% |
| 2021 | 20,930 | 70,497 | −49,567 | 68.9 | 0% |
| 2022 | 6,078 | 71,250 | −65,172 | 57.2 | 0% |
| 2023 | 272,121 | 112,776 | 159,345 | 53.1 | 0% |
In its most recent public year (2023), this organization brought in $159,345 more than it spent. Its reserves stood at about 53.1 months of spending, up from 8.7 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works